Biological Intellectual Property Protection Act of 2025
To restrict the export to foreign entities of concern of United States intellectual property and sensitive information related to synthetic biology, and for other purposes.
The Biological Intellectual Property Protection Act of 2025 aims to tighten controls on the export of U.S. intellectual property and sensitive synthetic biology information to entities that could pose a risk to national security. This bill targets foreign organizations that may use this information for harmful purposes, ensuring that critical biological research stays within secure hands. The act would primarily affect businesses, research institutions, and individuals involved in the export of such sensitive data.
As of December 11, 2025, the bill has been introduced and referred to the House Committee on Foreign Affairs. On April 22, 2026, the committee held a mark-up session and voted to report the bill with amendments. Key actions include the bill’s introduction, referral to the committee, and the committee’s subsequent review and recommendation for further legislative action.
This bill is currently under consideration, and the committee's report suggests it will move forward in its amended form. The next steps will likely involve further debate and possible votes in the House of Representatives.
